article thumbnail

Alzheimer’s vaccine granted Fast Track designation

European Pharmaceutical Review

AC Immune SA has received Fast Track designation from the US Food and Drug Administration (FDA) for its anti-amyloid beta (Abeta) active immunotherapy vaccine candidate for Alzheimer’s disease. The anti-Abeta therapy “specifically targets the most toxic forms of Abeta” according to Dr Andrea Pfeifer, CEO of AC Immune SA.

Vaccines 105
article thumbnail

RVAC and University of Pennsylvania to develop mRNA vaccines

Pharmaceutical Technology

The collaboration, under a sponsored research agreement, will focus on mRNA vaccines that can help in modulating the normal immune response of the body for the treatment of certain autoimmune diseases as well as allergic conditions. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Kite and Daiichi Sankyo update cell therapy licensing agreement

Pharmaceutical Technology

Directed against a cell membrane protein called CD19, Yescarta uses the immune system of the patient to destroy cancer. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy. By Cytiva Thematic.

article thumbnail

Market Your Pharmacy with a 2023 Health Awareness Calendar

Digital Pharmacist

World Immunization Week: April 24-30. National Immunization Awareness Month. Cervical Health Awareness Month | S hare downloadable content from the NCCC and advocate for HPV vaccinations. World Immunization Week | Post a flyer and share a list on social media of your vaccination offerings. . National Kidney Month.

article thumbnail

Hospital Universitario and Josep Carreras develop cell therapy for leukaemia

Pharmaceutical Technology

CAR-T therapies are based on the patient’s immune cell modification and can express artificial chimeric receptors that can identify and remove tumour cells. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy.

Hospitals 110
article thumbnail

Sanofi and Queensland collaborate to build $190m research facility

Pharmaceutical Technology

mRNA technology is projected to offer a new generation of vaccines that direct specific cells to generate proteins that are detected by the immune system to develop a defence. Additionally, the hub could bring more capabilities, supply-chain expertise and clinical assessments to the region. By Cytiva Thematic.

article thumbnail

4th Annual Cell Engager Summit | May 24-26 | Boston, MA

pharmaphorum

Learn all there is to know about the immune cell engager landscape, including clinical achievements, potential response predictors, and novel immune cell-based engager therapeutic discoveries. Download the full event guide to find out more. The post 4th Annual Cell Engager Summit | May 24-26 | Boston, MA appeared first on.